Patients as Partners Europe

Now Accepting Topic Submissions for 2025. Click here to learn more.

#PatientsEU2024
Patients as Partners Europe Demonstrated:

• How pharma and biotech companies can have a fully integrated approach to patient engagement
• An understanding on what the highest impact activities are to speed up medicine development
• Embedding patient engagement, diversity and access early in clinical research
• Multicultural aspect of patient engagement programs
• Collaboration, transparency and partnerships

Why now?

It is essential to understand how patient involvement in clinical research can accelerate medicine development, how it can improve better access, inclusivity and diversity. The medicine development community is figuring out how patient data is being used and must find solutions to return data back to patients. The R&D industry is also grappling with an understanding of how patient involvement can help advance sustainable clinical development? It is important to demonstrate the value of patient engagement in clinical trials and to know what’s on the regulatory landscape.

Experts from Sanofi, GSK, Boehringer Ingelheim, Lundbeck, Novartis, Pfizer, Ipsen, AstraZeneca, Roche and more gathered with patient advocacy to address:

• The future of patient informed research
• Understanding patient preferences and decentralized clinical trials
• Advancing health equity and diversifying clinical trials to engage underserved communities
• The patient experience data landscape and returning patient data
• Turning patient insights into action
• Mapping and how to measure patient engagement
• Patient burden-reducing solutions and technologies
• Regulatory requirements and patient engagement in drug development

Co-Chair
Victoria DiBiaso
Sanofi

Co-Chair
Alfred Samuels
Patient Advocate

Co-Chair
Nichola Gokool
Parexel

2024 Co-Chairs

2024 Keynotes and Featured Speakers

Keynote
Emma Lawton,
Patient Advocate

Keynote
Sarah Zenner Dolan,
Patient Advocate

Andrew Garvey,
Global Patient Advocacy Lead,
GSK

Patrick Gallogly,
Medical Advisor,
Pfizer

Anders Lassen,
Senior Director, Patient Insights,
Lundbeck

Annie Gilbert,
Global Patient Advocacy Lead
Boehringer Ingelheim

Sally Dews, Director, Global Patient Advocacy and External Partnerships
Pfizer UK

Lisa Kerr,
Senior Director, R&D Patient Science,
AstraZeneca

Patients as Partners® Multimedia Resources

Editorials:
Bi-monthly interviews with industry leaders in patient engagement.

Read Here

Podcasts:
Monthly discussions expanding on conference topics.

Listen Here

Webcasts:
Live and on-demand video sessions on timely topics.

Watch Here

What to Expect

The 8th annual #PatientsEU2024 conference offered an unparalleled opportunity to hear from pharma R&D and patient advocacy together on how patient involvement gets done to drive greater efficiencies in clinical research with better outcomes. The conference prioritized the patient voice for the R&D industry to learn how we can move into the next phase of patient centricity to better support access and decision-making for patients, increase diverse representation to connect with a wide range of patient communities, and how this transformation will make finding clinical research easier for patients and allow for faster and more efficient clinical development.

Patients First!

Thanks to patients, we have the following patient initiatives in place:

• Patient advisory groups to gain their input on the program agenda
• Patients have a wide choice of speaking opportunities
• Dedicated patient-led sessions, panels and roundtables
• Patients in clinical trials registration scholarship program covering 100% of the attendees registration fee